Literature DB >> 35051237

COVID-19 excess mortality among long-term care residents in Ontario, Canada.

Noori Akhtar-Danesh1,2, Andrea Baumann3, Mary Crea-Arsenio3, Valentina Antonipillai3.   

Abstract

The coronavirus disease 2019 (COVID-19) has had devastating consequences worldwide, including a spike in global mortality. Residents of long-term care homes have been disproportionately affected. We conducted a retrospective cohort study to determine the scale of pandemic-related deaths of long-term care residents in the province of Ontario, Canada, and to estimate excess mortality due to a positive COVID-19 test adjusted for demographics and regional variations. Crude mortality rates for 2019 and 2020 were compared, as were predictors of mortality among residents with positive and negative tests from March 2020 to December 2020. We found the crude mortality rates were higher from April 2020 to June 2020 and from November 2020 to December 2020, corresponding to Wave 1 and Wave 2 of the pandemic in Ontario. There were also substantial increases in mortality among residents with a positive COVID-19 test. The significant differences in excess mortality observed in relation to long-term care home ownership category and geographic region may indicate gaps in the healthcare system that warrant attention from policymakers. Further investigation is needed to identify the most relevant factors in explaining these differences.

Entities:  

Mesh:

Year:  2022        PMID: 35051237      PMCID: PMC8775534          DOI: 10.1371/journal.pone.0262807

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The coronavirus disease 2019 (COVID-19) has had devastating consequences worldwide, including a spike in global mortality. One group that has been disproportionately affected are residents of long-term care (LTC) homes. Compared with other Organisation for Economic Co-operation and Development countries, Canada had a relatively low overall COVID-19 mortality rate but the highest proportion of LTC deaths. Residents of LTC homes in Canada represented 81% of all reported COVID-19 deaths compared with an average of 38% in other countries [1]. Globally, countries have reported a significant number of COVID-related deaths in LTC settings. In Sweden, more than 50% of all deaths occurred in LTC homes, the highest among the Scandinavian countries [2]. In Italy, municipalities with care homes had higher rates of excess deaths related to COVID compared to those without a care home [3]. Excess deaths were estimated 7% in all care homes in England during the first 23 weeks of COVID-19; of those, 65% of all deaths were attributable to the virus [4]. Similarly, in Belgium residents of care homes were 130 times more likely to die from a COVID-19 infection than the rest of the population [5]. Finally, in a recent Canadian study of excess mortality, it was found that COVID-19 deaths in long-term care were approximately 50% greater than reported COVID-19 fatalities in Italy, Spain, the United Kingdom and United States [4]. Across Canadian regions, the percentage of COVID-19 fatalities reported in LTC has remained close to double the OECD average throughout the COVID-19 pandemic [4]. In the light of the impact of the pandemic on residents of long-term care homes, further investigation into excess mortality is required. Mortality is one indicator of how sectors such as LTC were able to protect their residents during the most severe stages of the pandemic. Using resident-level data from linked health administrative databases, this paper provides an analysis of the scale of COVID-19 deaths among LTC residents to further assess the extent of excess mortality from infection. The paper focuses on Canada’s most populous province of Ontario and one of the hardest hit during the pandemic [6]. There are 626 LTC homes in Ontario with approximately 78,000 residents at any one time [1]. Ownership, operation, and providers differ. Currently, 57% of the homes are for-profit and are privately owned, 27% are not-for-profit, and 16% are public and operated by municipalities [7]. From January 15, 2020, to February 28, 2021, there were 14,960 cases of COVID-19 among LTC residents in Ontario and 3871 deaths [8]. This represents 64.5% of all pandemic-related deaths in the province [9]. The incidence rate for COVID-19 deaths among LTC residents in Ontario was 13 times higher than the rate for adults 69 years of age or older living in the community [10]. Evidence demonstrates that for-profit LTC homes have lower levels of staffing, more complaints from residents and family, more acute care hospital admissions, and higher mortality rates [11, 12]. Lack of preparation, shortage of staff, and overcrowding have contributed to excess mortality in the LTC sector, and mortality increases with age and pre-existing medical conditions [13-16]. Furthermore, personal protective equipment, reduced use of part-time staff, and early implementation of infection protocols have been linked to lower rates of mortality in nursing homes [17]. We conducted a retrospective cohort study with the aim of understanding the scale of COVID-19 deaths among LTC residents in Ontario and estimating excess mortality due to a positive COVID-19 test adjusted for demographics and regional variations. For the purposes of the study, excess mortality was defined as an estimate of the additional number of deaths within 30 days of a COVID-19 test compared to the expected number of deaths [18]. It is a measure encompasses all causes of death, directly or indirectly associated with a positive COVID-19 test, and provides a metric of the overall mortality impact of the pandemic [19]. We found significant differences in excess mortality with regard to ownership category and geographic region of LTC homes. This may indicate gaps in the healthcare system that warrant attention from policymakers.

Materials and methods

Data sources

The study focused on LTC residents in Ontario from January 2019 to December 2020 and used population-based health administrative data sets from the Institute for Clinical Evaluative Sciences (ICES) and the Resident Assessment Instrument—Minimum Data Set (RAI-MDS) 2.0. The RAI-MDS contains information on resident clinical, functional, and psychosocial characteristics. The study obtained LTC home admission and discharge dates from the Continuing Care Reporting System (CCRS). COVID-19 testing and positivity data were obtained from linking these health administrative databases to the Ontario Laboratories Information System (OLIS), which acquires SARS-CoV-2 infection test data from hospitals, commercial laboratories, provincial public health laboratory and COVID-19 assessment centers. Mortality and demographic data were obtained through the Registered Persons Database (RPDB). The data sets were linked via unique encoded identifiers. The age groups for residents were coded as 65–69, 70–74, 75–79, 80–84, and ≥85 years. The following variables were included in the analysis for each resident: result of last COVID-19 test (positive or negative from March 2020); region of Ontario (Central, Southwest, East, North); income quintile based on postal code of the LTC home; frailty index (classified as robust, pre-frail, frail); ownership category of LTC home (municipal, non-profit, private); and Changes in Health, End-stage disease Symptoms and Signs Scales (CHESS) comorbidity score [20, 21]. The income quintile was coded as 1 (lowest income level) to 5 (highest income level). The CHESS score varies from 0 (no instability in health) to 5 (high unstable health). The study was conducted in accordance with the Declaration of Helsinki. The study was approved by authors’ institutional ethics board. ICES is a prescribed entity under section 45 of Ontario’s Personal Health Information Protection Act. Section 45 authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system. Projects conducted under section 45, by definition, do not require informed consent. This project was conducted under section 45 and approved by ICES’ Privacy and Legal Office.

Statistical analysis

Summary statistics were reported as mean and standard deviation (SD) for continuous variables and as frequency and percentage for categorical variables and were compared using t-tests and chi-squared tests, respectively. We compared crude mortality rate per 1000 person-months between 2019 and 2020. We first calculated the crude mortality rate per month from January 2019 to December 2020, where rate for each month in 2020 can be compared with the rate of same month in 2019. A flexible parametric model [22, 23] was used to estimate mortality rates based on COVID-19 test results from March 2020 to December 2020. The model provides smooth estimates of survival and mortality using restricted cubic splines on the log cumulative excess hazard scale. Compared to standard survival models such as Cox regression and parametric survival models, it adopts a piecewise approach and is more flexible in mimicking the actual trends in mortality (hazard rate [HR]) and survival patterns [24]. We fitted the model by incorporating age group, sex, region, income quintile, frailty index, CHESS score, ownership category, and interaction term between each two variables into a multiple statistical model using a forward approach. We used the likelihood ratio test to compare different models toward reaching a final model. All variables included in the final model were statistically significant. Statistical significance was evaluated with 2-sided p-values at a type I error rate of 0.05. Based on the final model, mortality was estimated for residents with positive or negative COVID-19 tests per 1000 person-days for over 30 days after each test while adjusting for the other variables in the model. The flexible parametric model was fitted using the freely available stpm2 program for Stata package [22]. All statistical analyses were conducted using Stata/MP 15.1 (Stata Corporation, College Station, TX).

Results

The study included a total of 120, 286 residents across the two years. In 2019 there were 102,897 LTC residents and in 2020 there were 89,034 LTC residents, of which 71, 645 were also residents in 2019. The crude mortality rates are depicted in Fig 1; compared to the same periods in 2019, crude mortality rate were higher from April 2020 to June 2020 and from November 2020 to December 2020, corresponding to Wave 1 and Wave 2 of the pandemic in Ontario.
Fig 1

Crude mortality rate based on year and COVID-19 test result.

Comparison of mortality rates from March 2020 to December 2020 between residents with positive and negative COVID-19 tests showed the rates for residents with negative tests were at the same level as in 2019, but there was significant variation for those with positive tests. The mortality rate increased sharply in April and May, decreased in June to September, and increased again in October to December. The spikes in mortality correspond to Wave 1 and Wave 2 of the pandemic. Table 1 presents the number and percentage of residents between March 2020 and December 2020 based on their COVID-19 test results and demographic variables. Although the COVID-19 positivity rate was statistically significant for every variable, there were substantial differences between categories for some variables such as region and LTC home ownership. For example, the positivity rate was 23.4% for Central Ontario compared to only 1.8% for Northern Ontario. In addition, it was 5.4% for municipally owned homes compared to 16.6% for privately owned for-profit homes.
Table 1

Distribution, n (%), of COVID-19 tests based on demographics from March 2020 to December 2020.

CategoryNegative TestPositive TestTotalP-value
Sex
    Male20,586 (87.0)3082 (13.0)23,6680.002
    Female45,150 (87.8)6282 (12.2)51,432-
Age group
    65–69 years3679 (86.4)579 (13.6)42850.001
    70–74 years5689 (86.7)872 (13.3)6561-
    75–79 years8413 (87.4)1211 (12.6)9624-
    80–84 years12,476 (87.1)1844 (12.9)14,320-
    ≥85 years35,479 (88.0)4858 (12.0)40,337-
Age: Mean (SD)84.3 (8.2)83.8 (8.2)84.3 (8.2)<0.001
CHESSa scale: Mean (SD)0.72 (0.83)0.60 (0.76)0.71 (0.83)<0.001
Region
     Central15,662 (76.6)4793 (23.4)20,455<0.001
    Southwest23,251 (92.3)1932 (7.7)25,183-
    East17,492 (87.7)2453 (12.3)19,945-
    North9287 (98.2)174 (1.8)9461-
Income quintile
    1 (lowest)19,946 (87.5)2796 (12.5)22,292<0.001
    213,917 (85.6)2333 (14.4)16,250-
    311,824 (87.6)1677 (12.4)13,501-
    410,940 (89.5)1284 (10.5)12,224-
    5 (highest)9029 (88.4)1183 (11.6)10,212-
Frailty index
    Robust8518 (87.6)1205 (12.4)9723<0.001
    Pre-frail21,666 (86.5)3381 (13.5)25,047-
    Frail34,963 (88.1)4737 (11.9)39,700-
Long-term care home ownership
    Municipal14,822 (94.6)850 (5.4)15,672<0.001
    Non-profit18,225 (90.0)2027 (10.0)20,252-
    Private32,672 (83.4)6487 (16.6)39,159-
Total 65,736 (87.5) 9364 (12.5) 75,100 -

aChanges in Health, End-stage disease and Symptoms and Signs.

aChanges in Health, End-stage disease and Symptoms and Signs. In the following, a death was counted for a resident if it occurred within 30 days of a COVID-19 test. International studies suggest that most deaths caused by COVID-19 among LTC home residents occur within the first 28 to 30 days after a SARS-CoV-2 diagnosis [25, 26]. After 30 days, death among residents is more likely to be attributable to another disease or underlying condition [26]. Table 2 shows large differences in mortality based on COVID-19 test results and demographics. The maximum difference between the youngest and oldest groups of residents with a negative test was 2.3%, but it was 13.81% for those with a positive test. According to the frailty index, there was a 3.31% difference between the youngest and oldest groups of residents with a negative test and a 12.45% difference for those with a positive test. Also, there was a maximum difference of 1.50% between geographical regions (Central vs. North) among residents with negative tests, but the difference increased to 11.44% (East vs. North) among residents with positive tests.
Table 2

Mortality rate (%) based on COVID-19 tests and demographics for March 2020 to December 2020.

CategoryNegative TestPositive TestTotal
Mortality rateP-valueMortality rateP-valueMortality rateP-value
Sex
    Male5.76<0.00132.18<0.0019.13<0.001
    Female4.18-21.27-6.24-
Age group
    65–69 years3.06-15.09-4.67-
    70–74 years3.59-17.76-5.45-
    75–79 years3.90<0.00119.62<0.0015.87<0.001
    80–84 years4.22-23.94-6.71-
    ≥85 years5.36-28.90-8.14-
Region
    Central5.38-23.59-9.60-
    Southwest4.44<0.00121.18<0.0015.67<0.001
    East4.78-30.49-7.91-
North3.88-19.05-4.16-
Income quintile
    1 (lowest)4.69-24.51-7.14-
    24.81-26.35-7.88-
    34.410.09825.340.2446.96<0.001
    44.40-23.61-6.37-
    5 (highest)5.11-23.36-7.17-
Frailty index
    Robust2.41-16.75-4.19-
    Pre-frail3.74<0.00121.61<0.0016.12<0.001
    Frail5.72-29.20-8.47-
Long-term care home ownership
    Municipal4.27-22.45-5.23-
    Non-profit4.43<0.00123.480.0446.32<0.001
    Private5.00-25.58-8.36-
In the following we compared overall mortality between positive and negative tests using a flexible parametric model while adjusting for the demographic and geographic factors. Therefore, the difference in mortality can be treated as the excess mortality between positive and negative tests. Potential predictors are shown in Table 3. The effects of each variable were adjusted for the other variables. There was an interaction between region of LTC home and COVID-19 test result. Using Central Ontario with negative test as the reference group, the highest risk of death for residents with positive tests was observed in Eastern Ontario (HR = 6.90; 95% CI: 6.24, 7.64), followed by Southwest Ontario (HR = 5.64; 95% CI: 5.00, 6.39), Central Ontario (HR = 5.27; 95% CI: 4.81, 5.78), and Northern Ontario (HR = 4.73; 95% CI: 3.32, 6.75).
Table 3

Predictors of death within 30 Days after COVID-19 test.

VariableHRa (95% CI)P-value
Region, COVID-19 test result
    Central, negativeReference group-
    Central, positive5.27 (4.81, 5.78)<0.001
    Southwest, negative0.77 (0.70, 0.84)<0.001
    Southwest, positive5.64 (5.00, 6.39)<0.001
    East, negative0.86 (0.78, 0.94)0.002
    East, positive6.90 (6.24, 7.64)<0.001
    North, negative0.73 (0.64, 0.82)<0.001
    North, positive4.73 (3.32, 6.75)<0.001
+ test interaction with time 1.06 (1.03, 1.08)<0.001
Sex
    MaleReference group-
    Female0.58 (0.55, 0.62)<0.001
Age group
    65–69 yearsReference group-
    70–74 years1.16 (0.97, 1.38)0.105
    75–79 years1.33 (1.12, 1.57)0.001
    80–84 years1.53 (1.31, 1.79)<0.001
    ≥85 years2.00 (1.73, 2.32)<0.001
CHESSb scale1.13 (1.09, 1.16)<0.001
Frailty index
    RobustReference group-
    Pre-frail1.44 (1.29, 1.61)<0.001
    Frail2.06 (1.85, 2.29)<0.001
Long-term care home ownership
    MunicipalReference group-
    Non-profit1.06 (0.97, 1.16)0.235
    Private1.25 (1.16, 1.35)<0.001

aHazard rate.

bChanges in Health, End-stage disease and Symptoms and Signs.

aHazard rate. bChanges in Health, End-stage disease and Symptoms and Signs. The risk of death for COVID-19 positive patients was time dependent and increased daily (HR for interaction between a positive test and time = 1.06; 95% CI: 1.03–1.08). Risk of death in private LTC homes was 25% higher than in municipal homes (HR = 1.25, 95% CI: 1.16–1.35). There was no significant difference in risk of death between non-profit LTC homes and municipal homes (p = 0.235). We also examined variation in mortality rate based on region and COVID-19 test result. Fig 2 shows the mortality rate (per 1000 person-day) for 30 days after a test. This figure is based on the final model and is adjusted for sex, age group, Changes in Health, End-stage disease and Symptoms and Signs (CHESS) scale, frailty, and long-term care home ownership.
Fig 2

Adjusted mortality rate based on region and COVID-19 test result adjusted for sex, age group, Changes in Health, End-stage disease and Symptoms and Signs (CHESS) scale, frailty, and long-term care home ownership.

Depending on the region, the mortality rate was at the highest level 3 to 5 days after a positive result and then subsided and plateaued after 20 days. We also estimated differences in mortality based on COVID-19 test as an approximate for excess mortality rate due to a positive test and found that excess mortality for a positive test started at 8 per 1000 person-days and increased sharply up to 4 days after the test (Fig 3). It then gradually decreased but remained elevated until 30 days after the test. The highest excess mortality was approximately 14 per 1000 person-days.
Fig 3

Excess mortality rate due to a positive COVID-19 test, adjusted for sex, age group, Changes in Health, End-stage disease and Symptoms and Signs (CHESS) scale, frailty, and long-term care home ownership.

Discussion

In this study, we compared crude mortality rates between 2019 and 2020 for LTC residents in Ontario. We also compared mortality rates between LTC residents with positive and negative COVID-19 tests. We chose to focus on deaths among LTC residents in Ontario as the rate of mortality was 13 times higher than the rate for older adults living in the community [10]. The difference in mortality was assumed to estimate the excess mortality due to a positive test. Our findings align with evidence indicating an excess number of deaths in LTC homes across Ontario and Canada as well as internationally [4, 9, 16, 17, 27–31]. Ontario’s Long-Term Care COVID-19 Commission reported the province "was not prepared for a pandemic and that the province’s long-term care homes, which had been neglected for decades by successive governments, were easy targets for uncontrolled outbreaks" ([32] p2). The stark difference in mortality observed in April 2020 and May 2020 coincides with Wave 1 of the pandemic in Ontario, during which there was insufficient personal preventive equipment for LTC staff and residents and no clear policies for LTC homes. For example, orders to limit the movement of LTC staff were not implemented until mid-April and were not initially applied to contract staff hired through employment agencies [33, 34]. When LTC homes managed to control the virus in June 2020, mortality rates for July to September decreased considerably and were slightly lower than the rates for the same period in 2019. For residents with positive COVID-19 tests, the drop in mortality for July to September is in keeping with other reports [9]. The decrease in mortality may be the result of various factors, including increased supports due to emergency funding from the provincial government and implementation of stricter rules in LTC homes [31]. Heightened screening, additional equipment, and containment strategies may have helped improve infection prevention and control in LTC homes during the summer months of 2020 [33]. The decrease in mortality could also be because the residents who survived Wave 1were younger or healthier at baseline. Yet the decrease was short lived as rates rose again in November 2020 and December 2020 during Wave 2. The results from our study revealed differences in mortality based on key demographic and regional variations. In addition to variables such as age group and sex for which higher mortality rates are usually expected at different levels, the difference in mortality based on LTC home ownership provides critical evidence for early findings. We determined that mortality rates in privately owned homes were 25% higher compared to municipally owned homes. Stall and colleagues [31] found that for-profit status was associated with an increase in the extent of an outbreak and the number of resident deaths when compared to municipal and not-for-profit homes. However, they concluded that these differences were explained by a higher prevalence of older design standards in for-profit LTC homes and chain ownership. The regional differences in excess mortality across LTC homes in Ontario suggest there may be gaps in the healthcare system that warrant attention from policymakers. Compared to Central Ontario, the test positivity rates for Eastern Ontario were almost half but the mortality rate was much higher. Research indicates that low population density within regions may be attributed to lower cumulative COVID-19 incidence rates in LTC homes [30, 31]. Our study demonstrates that even in areas with lower population densities additional factors may drive excess mortality. An international study of mortality in LTC homes determined that the share of resident deaths linked to COVID-19 was highly correlated to the number of COVID-19 deaths in the population that lived outside the homes [27].

Limitations

There are several limitations to the data set used in our analysis. As with all administrative databases and issues related to the pandemic, this study is subject to coding error. The nature of the study means we cannot make predictions or infer causality; we can only report associations. Furthermore, death secondary to COVID-19 was inferred based on a test positivity rate. However, exact cause of death was not recorded in some of the data sets. Testing data may not have captured all residents with COVID-19, as mandatory testing in LTC homes was not implemented until well into Wave 1 of the pandemic.

Conclusions

This study revealed important differences in mortality across years and positivity rates for residents of LTC homes in the largest Canadian province. Differences across regions and homes with various ownership models highlighted areas that require policy reform to improve resident care, especially during crises. Across the globe, countries have documented similar trends on the devastating effects of the pandemic on vulnerable populations living in long-term care homes. Findings from this study are an important contribution to the ongoing research about excess deaths due to COVID-19. The data provide evidence of the key factors that contributed to the increased number of deaths in long-term care. Future research is needed to identify the most relevant factors in explaining the differences between ownership models and regions as well as an analysis of excess mortality nationally.
  21 in total

1.  Hospitalization and Mortality Rates in Long-Term Care Facilities: Does For-Profit Status Matter?

Authors:  Peter Tanuseputro; Mathieu Chalifoux; Carol Bennett; Andrea Gruneir; Susan E Bronskill; Peter Walker; Douglas Manuel
Journal:  J Am Med Dir Assoc       Date:  2015-10-01       Impact factor: 4.669

2.  Association Between Nursing Home Crowding and COVID-19 Infection and Mortality in Ontario, Canada.

Authors:  Kevin A Brown; Aaron Jones; Nick Daneman; Adrienne K Chan; Kevin L Schwartz; Gary E Garber; Andrew P Costa; Nathan M Stall
Journal:  JAMA Intern Med       Date:  2021-02-01       Impact factor: 21.873

Review 3.  COVID-19 in long-term care homes in Ontario and British Columbia.

Authors:  Michael Liu; Colleen J Maxwell; Pat Armstrong; Michael Schwandt; Andrea Moser; Margaret J McGregor; Susan E Bronskill; Irfan A Dhalla
Journal:  CMAJ       Date:  2020-09-30       Impact factor: 8.262

4.  Descriptive epidemiology of deceased cases of COVID-19 reported during the initial wave of the epidemic in Canada, January 15 to July 9, 2020.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2020-10-01

5.  The MDS-CHESS scale: a new measure to predict mortality in institutionalized older people.

Authors:  John P Hirdes; Dinnus H Frijters; Gary F Teare
Journal:  J Am Geriatr Soc       Date:  2003-01       Impact factor: 5.562

6.  Survival prediction in nursing home residents using the Minimum Data Set subscales: ADL Self-Performance Hierarchy, Cognitive Performance and the Changes in Health, End-stage disease and Symptoms and Signs scales.

Authors:  Jenny S W Lee; Patsy P H Chau; Elsie Hui; Felix Chan; Jean Woo
Journal:  Eur J Public Health       Date:  2009-02-12       Impact factor: 3.367

7.  A Comparison of COVID-19 Mortality Rates Among Long-Term Care Residents in 12 OECD Countries.

Authors:  Edgardo R Sepulveda; Nathan M Stall; Samir K Sinha
Journal:  J Am Med Dir Assoc       Date:  2020-09-12       Impact factor: 4.669

8.  Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study.

Authors:  Marcello Morciano; Jonathan Stokes; Evangelos Kontopantelis; Ian Hall; Alex J Turner
Journal:  BMC Med       Date:  2021-03-05       Impact factor: 8.775

9.  For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths.

Authors:  Nathan M Stall; Aaron Jones; Kevin A Brown; Paula A Rochon; Andrew P Costa
Journal:  CMAJ       Date:  2020-07-22       Impact factor: 8.262

10.  Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19.

Authors:  Orestis A Panagiotou; Cyrus M Kosar; Elizabeth M White; Leonidas E Bantis; Xiaofei Yang; Christopher M Santostefano; Richard A Feifer; Carolyn Blackman; James L Rudolph; Stefan Gravenstein; Vincent Mor
Journal:  JAMA Intern Med       Date:  2021-04-01       Impact factor: 21.873

View more
  4 in total

1.  Comparison of pandemic excess mortality in 2020-2021 across different empirical calculations.

Authors:  Michael Levitt; Francesco Zonta; John P A Ioannidis
Journal:  Environ Res       Date:  2022-06-24       Impact factor: 8.431

Review 2.  COVID-19 prevalence and mortality in longer-term care facilities.

Authors:  Andrew T Levin; Juulia Jylhävä; Dorota Religa; Laura Shallcross
Journal:  Eur J Epidemiol       Date:  2022-04-10       Impact factor: 12.434

3.  Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update.

Authors:  Adam H Dyer; Aoife Fallon; Claire Noonan; Helena Dolphin; Cliona O'Farrelly; Nollaig M Bourke; Desmond O'Neill; Sean P Kennelly
Journal:  J Am Med Dir Assoc       Date:  2022-07-04       Impact factor: 7.802

4.  Excess death estimates from multiverse analysis in 2009-2021.

Authors:  Michael Levitt; Francesco Zonta; John P A Ioannidis
Journal:  medRxiv       Date:  2022-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.